These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3493475)

  • 21. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
    Lenoir AA; Granoff PD; Granoff DM
    Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer.
    Weisman SJ; Cates KL; Allegretta GJ; Quinn JJ; Altman AJ
    J Pediatr; 1987 Nov; 111(5):727-9. PubMed ID: 3499501
    [No Abstract]   [Full Text] [Related]  

  • 24. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
    Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
    N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
    Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
    Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
    Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
    J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
    Lucas AH; Azmi FH; Mink CM; Granoff DM
    J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional affinity of antibody to the Haemophilus influenzae type b polysaccharide.
    Griswold WR; Lucas AH; Bastian JF; Garcia G
    J Infect Dis; 1989 Jun; 159(6):1083-7. PubMed ID: 2786040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
    Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
    J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
    Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
    Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
    Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
    Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
    Granoff DM; Weinberg GA; Shackelford PG
    Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.
    Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R
    J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
    Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
    Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Haemophilus polysaccharide vaccine in a rural clinic setting.
    Ross SA; Darby CP; Harvell J; Watson C
    J S C Med Assoc; 1988 Mar; 84(3):105-8. PubMed ID: 3258942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.